Mouse Genetics Laboratory Shared Resource Summary The mission of the Mouse Genetics Laboratory (MGL) Shared Resource is to provide state-of-the-art services in generating new mouse models for users. Genetically modified mice have been vital tools for cancer studies for many years, enabling researchers to determine the roles of specific genes in cancer-relevant traits such as immune evasion, tumor initiation, and metastasis. MGL produces transgenic and knockout mice, cryopreserves mouse sperm and embryos, performs embryonic stem cell gene targeting, assists with mouse embryo manipulation, and provides scientific consultation. These services provide Masonic Cancer Center (MCC) members convenient, cost-effective access to genetically modified mice and associated technologies and are critical to the ongoing work of the Genetic Mechanisms, Immunology, and Cellular Mechanisms Programs of the MCC. As a new service, MGL now directly coordinates production of CRISPR/Cas9-altered mice with the Genome Engineering Shared Resource (GESR). GESR assists researchers with the design and generation of guide RNA and validates their efficacy, and then MGL generates mice with the edited genome. MGL is now led by Dr. Timothy Hallstrom (CM) who has 10 years of experience with mouse genetics research. He is the PI of an NCI R01 and leads a research laboratory focused on the cellular mechanisms controlling the retinoblastoma (Rb) protein. Day-to-day operations of the MGL are managed by Yun You, PhD, who was previously the supervisor of the Transgenic Group in the Mouse Genetic Core Facility at Memorial Sloan Kettering Cancer Center and was recruited in 2016 to supervise the operations of the MGL and to educate users of the laboratory on policies, protocols, and maintenance of transgenic mouse strains. In the last funding period, MGL moved to the new Cancer and Cardiovascular Research Building. This places the resource in close proximity to a large number of investigators in the Biomedical Discovery District, including members of the MCC and Academic Health Center groups such as the Stem Cell Institute, Institute for Translational Neuroscience, and Lillehei Heart Institute.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA077598-22
Application #
9859363
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Mondragon-Gonzalez, Ricardo; Perlingeiro, Rita C R (2018) Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech 11:
Kim, J-H; Frantz, A M; Sarver, A L et al. (2018) Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 16:E176-E184
Jin, Jin; Zhang, Lin; Leng, Ethan et al. (2018) Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Stat Med 37:3214-3229
Pierpont, Elizabeth I; Hudock, Rebekah L; Foy, Allison M et al. (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21
Carlson, Erik S; Upadhyaya, Pramod; Villalta, Peter W et al. (2018) Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-p Chem Res Toxicol 31:358-370
Lin, Lifeng; Chu, Haitao; Murad, Mohammad Hassan et al. (2018) Empirical Comparison of Publication Bias Tests in Meta-Analysis. J Gen Intern Med 33:1260-1267
Rashidi, Armin; Ebadi, Maryam; Said, Bassil et al. (2018) Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect. Am J Hematol :
Bejanyan, Nelli; Brunstein, Claudio G; Cao, Qing et al. (2018) Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv 2:909-922
Bachanova, Veronika; Sarhan, Dhifaf; DeFor, Todd E et al. (2018) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunol Immunother 67:483-494
Hupp, Meghan; Williams, Sarah; Dunnette, Brian et al. (2018) Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas. Hum Pathol :

Showing the most recent 10 out of 1013 publications